Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Termination of Gilead-Glaxo Wellcome code blocker collaboration

June 30, 1998

Ventana Genetics reports novel method for identification of drug target sites

June 29, 1998

Cellegy and 3M combine technologies

June 29, 1998

AxyS enters agreement with Parke-Davis

June 25, 1998

Celsion and Duke University enter oncology alliance

June 25, 1998

Sheffield and Zambon collaborate on MSI delivery system for respiratory drugs

June 24, 1998

AxyS and Roche Bioscience embark on functional genomics collaboration

June 23, 1998

Wyeth-Ayerst and ArQule sign five-year drug discovery collaboration

June 23, 1998

Rhone-Poulenc Rorer and IRORI enter combinatorial chemistry strategic alliance

June 23, 1998

Genelabs Technologies receives additional patent protection for drug discovery technology

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...